522. Significant Improvement in Health-Related Quality of Life (HRQL) with RBX2660: Results from a Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides Difficile Infection (PUNCH CD3)

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC9751853 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature